Harvey, which builds generative AI tools for law firms using OpenAI's tech, raised an $80M Series B co-led by Elad Gil and Kleiner Perkins at a $715M valuation
Isabel Gottlieb / Bloomberg Law :
Context & Ripple Effects
Harvey's Series B follows its $21M Series A for generative-AI legal tools, which included the OpenAI Startup Fund. The new round brings Kleiner Perkins and Elad Gil in as co-leads while retaining the company’s connection to OpenAI technology.
The financing matters because it places a legal-software application, rather than a model developer, at a $715M valuation—an early test of whether specialized AI products can attract large venture backing.
First-order effects
- Harvey gains $80M to fund its legal-AI product and commercial expansion, while co-leads Elad Gil and Kleiner Perkins acquire a direct financial stake at the $715M valuation.
- Law firms evaluating generative-AI tools now face a better-capitalized Harvey backed by investors with the resources to support a longer buildout.
Second-order effects
- Other legal-AI vendors may face greater pressure to demonstrate differentiated workflows, customer adoption, or similarly strong model-provider relationships when competing for firm budgets and venture capital.
- The round strengthens the commercial position of applications built on OpenAI’s technology, giving legal buyers another reason to assess AI tools as vendor products rather than experimental pilots.
Third-order effects
- If specialist products such as Harvey continue raising at this scale, value creation in generative AI may increasingly concentrate in vertical software layers that package general-purpose models into regulated, high-value workflows.
- That shift would make durable customer trust, workflow integration, and access to capable underlying models more important competitive gates than model access alone.
The trend: Generative AI is moving from broad model availability toward heavily funded, industry-specific software designed to operationalize it in professional workflows.